Angel Maldonado

Angel Maldonado

Auto-generated profile, based on publicly available information

Angel Maldonado

Department of Biochemistry and Molecular Biology, School of Chemistry Complutense University of Madrid Madrid Spain

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 August 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
CSCarmen Sevilla-Ortega
Carmen Sevilla-Ortega
AAAlba Angelina
Alba Angelina
LMLeticia Martín-Cruz
Leticia Martín-Cruz
MPMario Pérez-Diego
Mario Pérez-Diego
AMAngel Maldonado
Angel Maldonado
OPOscar Palomares
Oscar Palomares
Allergic sensitization and viral infections are risk factors for asthma development and progression. Sublingual vaccination with MV130, a whole heat-inactivated polybacterial preparation, protects against viral infections, but its impact on allergic sensitization and asthma development remains unknown. Here we show MV130 prevents house dust mite (HDM)-induced local type 2 immune responses and associated eosinophilic airway inflammation, conferring protection up to 9 weeks after vaccination. MV130 reduces pathophysiological and clinical asthma features in an in vivo experimental mouse model of HDM-induced allergic eosinophilic asthma, restoring normal airway functionality. MV130 impairs allergen-specific IgE sensitization and systemic type 2 inflammation endorsing type 1 and IL-10 responses. In human DCs, MV130 induces a transcriptomic and metabolic reprogramming, and restores non-pathological immune responses to allergens in healthy and asthmatic donors. Additionally, the adoptive transfer of MV130-stimulated BMDCs was sufficient to reproduce the protective features of the vaccine administration in vivo. Collectively, we show MV130 reduces allergic sensitization and eosinophilic asthma. Our findings support the exploration of mucosal interventions aimed at reducing the risk of allergen-induced asthma development.

8 August 2026 in Allergy
Verified
Journal Article
Open access
PDF file
DYDuygu Yazici
Duygu Yazici
YHYuka Hayashi
Yuka Hayashi
YPYagiz Pat
Yagiz Pat
JHJennifer Hotie
Jennifer Hotie
MBMehmet Ali Balci
Mehmet Ali Balci
CACezmi A. Akdis
Cezmi A. Akdis
The global rise in allergic and autoimmune diseases since the 1960s has been associated with environmental disruptions of epithelial barriers, particularly in the gastrointestinal tract. Among the implicated factors are food emulsifiers, which have become increasingly prevalent in processed foods such as peanut butter. This study investigates the biological effects of two commonly used food emulsifiers in peanut butter, soy lecithin and diacetyl tartaric acid esters of mono‐ and diglycerides (DATEM), on gastrointestinal tissue responses and immune responses using advanced in vitro gut‐on‐a‐chip models, human adult stem cell‐derived colon organoids‐on‐a‐chip, and murine models. Both emulsifiers induced dose‐dependent cytotoxicity and disrupted epithelial barriers, as demonstrated by reduced transepithelial electrical resistance and disorganization of zona occludens‐1 at daily‐exposure doses. Transcriptomic and proteomic analyses revealed activation of pro‐inflammatory pathways including TNF, NF‐κB, the unfolded protein response, and cell death by apoptosis. Soy lecithin additionally induced oxidative stress. Systemic responses were confirmed by increased pro‐inflammatory cytokines in serum and immune activation in peripheral blood mononuclear cells (PBMCs). Notably, both emulsifiers stimulated serum total IgG, soy lecithin induced IgE in mice upon feeding, and DATEM enhanced IL‐4‐induced IgE production in human PBMCs, suggesting a role in allergy development. These findings challenge the presumed safety of soy lecithin and DATEM and highlight their potential contribution to immune dysregulation and epithelial barrier dysfunction, which may initiate or exacerbate food allergy and gastrointestinal inflammatory diseases.

31 July 2026 in Allergy
Verified
Journal Article
Closed access
PDF file
LMLeticia Martín‐Cruz
Leticia Martín‐Cruz
ARAndrés de la Rocha‐Muñoz
Andrés de la Rocha‐Muñoz
IPIsabel María Peñalver‐Fernández
Isabel María Peñalver‐Fernández
ÁMÁngel Maldonado
Ángel Maldonado
SSSofía Sirvent
Sofía Sirvent
OPOscar Palomares
Oscar Palomares